Events and training April 15, 2024
Reducing infection with catheter care bundles
Catheter-related bloodstream infections (CRBSIs) are a serious threat to patients with a vascular access device, yet many are preventable using…
Reducing infection with catheter care bundles
Catheter-related bloodstream infections (CRBSIs) are a serious threat to patients with a vascular access device, yet many are preventable using…
Scientific evidence on VATs: Is there enough? Is it robust?
There is much scientific evidence available on the efficacy of vascular access teams (VATs) in managing costs, preventing intravenous (IV)…
BD IV News 2.0: building an IV therapy community
Your source of information on IV therapy just got a whole lot better. Following feedback from readers, BD IV News…
Device and drug shortages in Europe persist, new survey shows
Countries across the globe face a wide range of challenges in accessing necessary health products, such as shortages and stockouts.1…
How to turn a PICC team into a vascular access team
On the second day of BD MACOV@23, a virtual edition of the Multidisciplinary Advanced Course on Vascular Access (MACOVA) held…
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…